Patents by Inventor Noriaki TAKASU

Noriaki TAKASU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified biotin, streptavidin mutant, and usage of them
    Patent number: 11286285
    Abstract: An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, and usage of them.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 29, 2022
    Assignee: SAVID THERAPEUTICS INC.
    Inventors: Akira Sugiyama, Hirofumi Doi, Tatsuhiko Kodama, Tsuyoshi Inoue, Eiichi Mizohata, Tatsuya Kawato, Tomohiro Meshizuka, Motomu Kanai, Yohei Shimizu, Noriaki Takasu, Mari Takatsu
  • Modified biotin, streptavidin mutant, and usage of them
    Patent number: 11161884
    Abstract: An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, angsd usage of them.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: November 2, 2021
    Assignee: SAVID THERAPEUTICS INC.
    Inventors: Akira Sugiyama, Hirofumi Doi, Tatsuhiko Kodama, Tsuyoshi Inoue, Eiichi Mizohata, Tatsuya Kawato, Tomohiro Meshizuka, Motomu Kanai, Yohei Shimizu, Noriaki Takasu, Mari Takatsu
  • Modified biotin, streptavidin mutant, and usage of them
    Patent number: 11124549
    Abstract: An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, angsd usage of them.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: September 21, 2021
    Assignee: SAVID THERAPEUTICS INC.
    Inventors: Akira Sugiyama, Hirofumi Doi, Tatsuhiko Kodama, Tsuyoshi Inoue, Eiichi Mizohata, Tatsuya Kawato, Tomohiro Meshizuka, Motomu Kanai, Yohei Shimizu, Noriaki Takasu, Mari Takatsu
  • MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM
    Publication number: 20200017558
    Abstract: An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, angsd usage of them.
    Type: Application
    Filed: July 16, 2019
    Publication date: January 16, 2020
    Applicant: SAVID THERAPEUTICS INC.
    Inventors: Akira SUGIYAMA, Hirofumi DOI, Tatsuhiko KODAMA, Tsuyoshi INOUE, Eiichi MIZOHATA, Tatsuya KAWATO, Tomohiro MESHIZUKA, Motomu KANAI, Yohei SHIMIZU, Noriaki TAKASU, Mari TAKATSU
  • MODIFIED BIOTIN, STREPTAVIDIN MUTANT, AND USAGE OF THEM
    Publication number: 20170145063
    Abstract: An object of this invention is to provide a streptavidin mutant reduced in affinity to the naturally-occurring biotin, and to provide a modified biotin which shows a high affinity to such streptavidin mutant reduced in affinity to the naturally-occurring biotin. This invention can provide a compound composed of a dimer of modified biotin, a streptavidin mutant, and usage of them.
    Type: Application
    Filed: February 18, 2015
    Publication date: May 25, 2017
    Applicant: SAVID THERAPEUTICS INC.
    Inventors: Akira SUGIYAMA, Hirofumi DOI, Tatsuhiko KODAMA, Tsuyoshi INOUE, Eiichi MIZOHATA, Tatsuya KAWATO, Tomohiro MESHIZUKA, Motomu KANAI, Yohei SHIMIZU, Noriaki TAKASU, Mari TAKATSU